









Markets
/
Stocks
/
nasdaq-glue
/

Monte Rosa Therapeutics Inc

GLUE

4.880USD

+0.090+1.88%

Close 08/04, 16:00（ET）Quotes delayed by 15 min

300.17MMarket Cap

48.78P/E TTM



Monte Rosa Therapeutics Inc

4.880

+0.090+1.88%

Overview Company Financials

Overview

Company

Financials

Statements

Income Statement

Balance Sheet

Cash Flow Statement

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-19.20%-45.49M

335.05%128.92M

15.02%-20.99M

-9.65%-27.77M

-63.06%-38.16M

223.68%29.63M

-19.93%-24.71M

-23.53%-25.32M

14.59%-23.41M

-69.07%-23.96M

-15.77%-20.60M

-50.94%-20.50M

-98.36%-27.40M

-65.29%-14.17M

-158.22%-17.79M

-222.46%-13.58M

-309.21%-13.81M

---8.57M

---6.89M

---4.21M

---3.38M

Net income from continuing operations

246.66%46.88M

140.41%13.44M

31.60%-23.86M

13.84%-30.31M

0.22%-31.97M

-8.02%-33.25M

-27.70%-34.88M

-32.90%-35.18M

-33.87%-32.04M

-31.32%-30.78M

-37.71%-27.32M

-43.81%-26.47M

-94.95%-23.93M

-19.25%-23.44M

-202.53%-19.84M

-243.12%-18.41M

-185.36%-12.28M

---19.66M

---6.56M

---5.36M

---4.30M

Operating gains losses

7.96%2.05M

11.65%2.06M

14.67%2.10M

48.09%2.06M

64.81%1.90M

72.52%1.85M

77.54%1.83M

56.47%1.39M

52.86%1.15M

32.26%1.07M

77.49%1.03M

90.36%889.00K

174.82%753.00K

262.78%809.00K

240.35%582.00K

548.61%467.00K

285.92%274.00K

--223.00K

--171.00K

--72.00K

--71.00K

Other non-cash items

-1391.30%-1.03M

5.56%-696.00K

-119.11%-1.09M

22.63%-1.09M

94.55%-69.00K

-309.38%-737.00K

-141.80%-497.00K

-242.25%-1.41M

-479.04%-1.27M

--352.00K

--1.19M

--994.00K

--334.00K

----

Change in working capital

-664.73%-98.64M

90.03%109.65M

-155.59%-2.43M

-150.89%-2.92M

-377.85%-12.90M

2683.55%57.70M

245.42%4.37M

374.26%5.75M

169.44%4.64M

-68.59%2.07M

302.56%1.27M

-63.68%1.21M

-120.99%-6.69M

121.59%6.60M

-13.64%-625.00K

239.47%3.34M

-458.41%-3.02M

--2.98M

---550.00K

--983.00K

--844.00K

-Change in receivables

----

--9.00M

---9.00M

----

-Change in prepaid expenses

99.83%-4.00K

338.17%3.35M

-975.74%-2.53M

-106.70%-125.00K

-73.26%-2.29M

15400.00%765.00K

83.61%-235.00K

2433.75%1.87M

-117.11%-1.32M

-100.56%-5.00K

36.44%-1.43M

-103.91%-80.00K

55.97%-608.00K

226.82%889.00K

-1364.94%-2.26M

490.08%2.04M

-69150.00%-1.38M

---701.00K

---154.00K

---524.00K

--2.00K

-Change in other current liabilities

-7023.76%-83.63M

79.18%89.32M

-22900.00%-8.97M

62557.14%4.39M

-16671.43%-1.17M

207612.50%49.85M

-277.27%-39.00K

153.85%7.00K

-117.07%-7.00K

-97.84%24.00K

--22.00K

---13.00K

--41.00K

--1.11M

----

Cash from non-recurring investing activities

Cash from operating activities

-19.20%-45.49M

335.05%128.92M

15.02%-20.99M

-9.65%-27.77M

-63.06%-38.16M

223.68%29.63M

-19.93%-24.71M

-23.53%-25.32M

14.59%-23.41M

-69.07%-23.96M

-15.77%-20.60M

-50.94%-20.50M

-98.36%-27.40M

-65.29%-14.17M

-158.22%-17.79M

-222.46%-13.58M

-309.21%-13.81M

---8.57M

---6.89M

---4.21M

---3.38M

Investing cash flow

Net cash from continuing investing activities

14.67%1.59M

-89.17%183.00K

-75.95%399.00K

-68.65%2.02M

-84.93%1.38M

-76.77%1.69M

17.16%1.66M

152.64%6.45M

487.77%9.18M

143.99%7.27M

-19.32%1.42M

-5.48%2.55M

-29.54%1.56M

151.26%2.98M

88.71%1.75M

114.37%2.70M

16953.85%2.22M

--1.19M

--930.00K

--1.26M

--13.00K

Capital expenditures

14.67%1.59M

-89.17%183.00K

-75.95%399.00K

-68.95%2.02M

-84.93%1.38M

-76.77%1.69M

17.16%1.66M

155.07%6.51M

444.22%9.18M

137.69%7.27M

-19.32%1.42M

-5.48%2.55M

-23.91%1.69M

157.93%3.06M

88.71%1.75M

114.37%2.70M

16953.85%2.22M

--1.19M

--930.00K

--1.26M

--13.00K

Net cash flow from disposal of fixed assets

14.67%1.59M

-89.17%183.00K

-75.95%399.00K

-68.65%2.02M

-84.93%1.38M

-76.77%1.69M

17.16%1.66M

152.64%6.45M

487.77%9.18M

143.99%7.27M

-19.32%1.42M

-5.48%2.55M

-29.54%1.56M

151.26%2.98M

88.71%1.75M

114.37%2.70M

16953.85%2.22M

--1.19M

--930.00K

--1.26M

--13.00K

Net cash flow from investment products

-977.83%-98.64M

-292.12%-30.71M

2.31%38.15M

-336.54%-59.14M

-61.92%11.24M

134.25%15.99M

20.65%37.29M

313.75%25.00M

116.49%29.51M

---46.67M

--30.91M

---11.70M

---178.96M

----

Net cash flow from other investing activities

----

---67.00K

--67.00K

----

Cash from non-current investing activities

Net cash flow from investing activities

-1117.24%-100.23M

-316.10%-30.90M

5.95%37.75M

-429.69%-61.16M

-51.53%9.85M

126.51%14.30M

20.82%35.63M

230.18%18.55M

111.26%20.33M

-1670.23%-53.94M

1846.98%29.49M

-427.55%-14.25M

-8042.53%-180.52M

-156.91%-3.05M

-81.51%-1.69M

-114.37%-2.70M

-16953.85%-2.22M

---1.19M

---930.00K

---1.26M

---13.00K

Financing cash flow

Cash flow from continuous financing activities

-94.31%14.00K

-97.58%608.00K

-98.64%15.00K

8068.58%98.02M

1266.67%246.00K

23.19%25.17M

607.37%1.10M

1150.00%1.20M

-88.24%18.00K

15236.30%20.43M

-100.74%-217.00K

-99.95%96.00K

-99.89%153.00K

-1250.00%-135.00K

-38.31%29.46M

1567.52%205.47M

--142.77M

---10.00K

--47.75M

--12.32M

--0.00

Net cash flow from common stock issuance/repurchase

----

--0.00

--47.95M

----

--20.05M

-100.00%0.00

----

--0.00

--31.01M

--206.74M

----

Net cash flow from preferred stock issuance/repurchase

----

--0.00

-100.00%0.00

--0.00

-100.00%0.00

--143.00M

--0.00

--48.00M

--12.50M

--0.00

Proceeds from stock option exercised by employees

-94.31%14.00K

110.38%608.00K

-98.64%15.00K

-40.08%719.00K

1266.67%246.00K

-35.35%289.00K

1293.67%1.10M

1150.00%1.20M

-88.24%18.00K

2028.57%447.00K

--79.00K

-25.00%96.00K

--153.00K

--21.00K

--0.00

--128.00K

----

Proceeds from issuance of warrants

----

-100.00%0.00

--0.00

--49.36M

----

--24.88M

----

Net cash flow from other financing activities

----

100.00%0.00

----

56.41%-68.00K

80.96%-296.00K

100.00%0.00

-1460.00%-156.00K

-517.06%-1.56M

-683.71%-1.40M

---231.00K

---10.00K

---252.00K

---178.00K

--0.00

Net cash from non-recurrent financing activities

Net cash from financing activities

-94.31%14.00K

-97.58%608.00K

-98.64%15.00K

8068.58%98.02M

1266.67%246.00K

23.19%25.17M

607.37%1.10M

1150.00%1.20M

-88.24%18.00K

15236.30%20.43M

-100.74%-217.00K

-99.95%96.00K

-99.89%153.00K

-1250.00%-135.00K

-38.31%29.46M

1567.52%205.47M

--142.77M

---10.00K

--47.75M

--12.32M

--0.00

Net cash flow

Beginning cash balance

72.68%229.12M

105.24%130.48M

120.57%113.71M

83.12%104.61M

120.44%132.68M

-45.96%63.58M

-52.70%51.55M

-60.23%57.13M

-82.87%60.19M

-68.09%117.66M

-69.62%108.98M

-15.31%143.64M

719.84%351.41M

600.63%368.76M

2723.78%358.79M

2796.17%169.60M

363.63%42.86M

--52.63M

--12.71M

--5.86M

--9.24M

Current period cash flow changes

-419.16%-145.71M

42.73%98.63M

39.48%16.77M

263.22%9.10M

-816.59%-28.07M

220.25%69.10M

38.64%12.02M

83.92%-5.57M

98.53%-3.06M

-231.14%-57.47M

-13.05%8.67M

-118.32%-34.65M

-263.94%-207.77M

-77.63%-17.35M

-75.02%9.97M

2661.88%189.19M

3839.66%126.74M

---9.77M

--39.93M

--6.85M

---3.39M

Ending cash balance

-20.27%83.41M

72.68%229.12M

105.24%130.48M

120.57%113.71M

83.12%104.61M

120.44%132.68M

-45.96%63.58M

-52.70%51.55M

-60.23%57.13M

-82.87%60.19M

-68.09%117.66M

-69.62%108.98M

-15.31%143.64M

719.84%351.41M

600.63%368.76M

2723.78%358.79M

2796.17%169.60M

--42.86M

--52.63M

--12.71M

--5.86M

Free cash flow

-19.04%-47.08M

360.69%128.74M

18.86%-21.39M

6.43%-29.79M

-21.36%-39.55M

189.48%27.95M

-19.75%-26.36M

-38.09%-31.84M

-12.02%-32.59M

-81.25%-31.23M

-12.62%-22.02M

-41.58%-23.05M

-81.46%-29.09M

-76.55%-17.23M

-149.96%-19.55M

-197.57%-16.28M

-373.06%-16.03M

---9.76M

---7.82M

---5.47M

---3.39M

Currency unit

USD

Audit opinions

KeyAI

